Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Clinical trial NCT00800605 · COMPLETED
Trial details
- NCT number
- NCT00800605
- Sponsor
- Alachua Government Services, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2009-05-01
- Enrollment
- 7250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.